Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Oberlin, O"" wg kryterium: Autor


Tytuł :
The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer.
Autorzy :
Mansouri I; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Allodji RS; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Hill C; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
El-Fayech C; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.; Department of Childhood and Adolescent Oncology, Gustave Roussy, Villejuif, France.
Pein F; Institut de Cancérologie de l'Ouest ICO Centre René Gauducheau, Saint-Herblain (Nantes), France.
Diallo S; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.; Centre Hospitalier de Gonesse, Gonesse, France.
Schwartz B; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Vu-Bezin G; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Veres C; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.; Institut Curie, Paris, France.
Souchard V; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Dumas A; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Bolle S; Departement of Radiotherapy, Gustave Roussy, Villejuif, France.
Thomas-Teinturier C; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.; Department of Pediatric Endocrinology, AP-HP Hôpitaux Paris-Sud, Le Kremlin Bicêtre, France.
Pacquement H; Institut Curie, Paris, France.
Munzer M; Institut Jean Godinot, Reims, France.
Bondiau PY; Centre Antoine Lacassagne, Nice, France.
Berchery D; Centre Claudius Régaud, Toulouse, France.
Fresneau B; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.; Department of Childhood and Adolescent Oncology, Gustave Roussy, Villejuif, France.
Oberlin O; Department of Childhood and Adolescent Oncology, Gustave Roussy, Villejuif, France.
Diallo I; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
De Vathaire F; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Haddy N; CESP, Université Paris-Saclay, Villejuif, France.; CESP, INSERM U 1018, Cancer and Radiation team, Gustave Roussy, Villejuif, France.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2019 Apr; Vol. 21 (4), pp. 509-518. Date of Electronic Publication: 2018 Dec 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiac Volume/*radiation effects
Cardiotoxicity/*physiopathology
Heart/*radiation effects
Heart Failure/*physiopathology
Neoplasms/*radiotherapy
Radiotherapy/*adverse effects
Adult ; Anthracyclines/adverse effects ; Anthracyclines/therapeutic use ; Cardiac Volume/drug effects ; Cardiotoxicity/etiology ; Case-Control Studies ; Child ; Child, Preschool ; Dose-Response Relationship, Radiation ; Female ; Heart/drug effects ; Heart Failure/chemically induced ; Heart Failure/etiology ; Heart Ventricles/drug effects ; Heart Ventricles/radiation effects ; Humans ; Male ; Radiation Dosage
Czasopismo naukowe
Tytuł :
Fecundity and Quality of Life of Women Treated for Solid Childhood Tumors Between 1948 and 1992 in France.
Autorzy :
Thouvenin-Doulet S; 1 Paediatric Haematology and Oncology Unit, University Hospital , Saint-Etienne, France .
Berger C; 1 Paediatric Haematology and Oncology Unit, University Hospital , Saint-Etienne, France .; 2 Childhood Cancer Registry of the Rhône-Alpes Region, University of Saint Etienne , Saint-Etienne, France .; 3 Clinical and Exercise Physiology Laboratory, (EA 4607 SNA EPIS), University Hospital , Saint-Etienne, France .
Casagranda L; 1 Paediatric Haematology and Oncology Unit, University Hospital , Saint-Etienne, France .; 2 Childhood Cancer Registry of the Rhône-Alpes Region, University of Saint Etienne , Saint-Etienne, France .; 3 Clinical and Exercise Physiology Laboratory, (EA 4607 SNA EPIS), University Hospital , Saint-Etienne, France .; 4 Department of Public Health and Medical Informatics, University of Saint Etienne , Saint-Etienne, France .
Oberlin O; 5 Department of Paediatric Oncology, Institut Gustave Roussy , Villejuif, France .
Marec-Berard P; 6 Department of Paediatric Oncology, Institute of Paediatric Haematology and Oncology , Lyon, France .
Pacquement H; 7 Department of Paediatric Oncology, Institut Curie , Paris, France .
Guibout C; 5 Department of Paediatric Oncology, Institut Gustave Roussy , Villejuif, France .; 8 Inserm, U1018, Radiation Epidemiology Team, CESP Centre for Research in Epidemiology and Population Health , Villejuif, France .; 9 Faculté de Médecine, Université Paris XI , Villejuif, France .
Freycon C; 10 Paediatric Haematology and Oncology Unit, University Hospital of Grenoble , Grenoble, France .
N'Guyen TD; 11 Department of Paediatric Oncology, Institut Jean Godinot , Reims, France .
Bondiau PY; 12 Department of Paediatric Oncology, Centre Antoine Lacassagne , Nice, France .
Laprie A; 13 Department of Paediatric Oncology, Centre Claudius Régaud , Toulouse, France .
Berchery D; 13 Department of Paediatric Oncology, Centre Claudius Régaud , Toulouse, France .
El-Fayech C; 5 Department of Paediatric Oncology, Institut Gustave Roussy , Villejuif, France .; 8 Inserm, U1018, Radiation Epidemiology Team, CESP Centre for Research in Epidemiology and Population Health , Villejuif, France .; 9 Faculté de Médecine, Université Paris XI , Villejuif, France .
Trombert-Paviot B; 2 Childhood Cancer Registry of the Rhône-Alpes Region, University of Saint Etienne , Saint-Etienne, France .; 3 Clinical and Exercise Physiology Laboratory, (EA 4607 SNA EPIS), University Hospital , Saint-Etienne, France .; 4 Department of Public Health and Medical Informatics, University of Saint Etienne , Saint-Etienne, France .
de Vathaire F; 5 Department of Paediatric Oncology, Institut Gustave Roussy , Villejuif, France .; 8 Inserm, U1018, Radiation Epidemiology Team, CESP Centre for Research in Epidemiology and Population Health , Villejuif, France .; 9 Faculté de Médecine, Université Paris XI , Villejuif, France .
Pokaż więcej
Źródło :
Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2018 Aug; Vol. 7 (4), pp. 415-423. Date of Electronic Publication: 2018 May 31.
Typ publikacji :
Historical Article; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Fertility/*physiology
Neoplasms/*complications
Quality of Life/*psychology
Adolescent ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; France ; History, 20th Century ; Humans ; Infant ; Infant, Newborn ; Neoplasms/pathology ; Survivors/psychology
Czasopismo naukowe
Tytuł :
The right to be forgotten: a change in access to insurance and loans after childhood cancer?
Autorzy :
Dumas A; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France. .; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France. .
Allodji R; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Fresneau B; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France.
Valteau-Couanet D; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France.
El-Fayech C; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France.
Pacquement H; Department of Paediatric Oncology, Institut Curie, 75005, Paris, France.
Laprie A; Department of Radiation Oncology, Centre Claudius Regaud, 31059, Toulouse, France.
Nguyen TD; Radiotherapy Department, Centre Jean Godinot, 51100, Reims, France.
Bondiau PY; Department of Radiation Oncology, Centre Antoine Lacassagne, 06100, Nice, France.
Diallo I; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Guibout C; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Rubino C; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Haddy N; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Oberlin O; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805, Villejuif, France.
Vassal G; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
de Vathaire F; Centre for Research in Epidemiology and Population Health (CESP), Cancer and Radiation team, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, 94807, Villejuif, France.; Department of Clinical Research, Gustave Roussy, 114 Rue Edouard Vaillant, 94805, Villejuif, France.
Pokaż więcej
Źródło :
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2017 Aug; Vol. 11 (4), pp. 431-437. Date of Electronic Publication: 2017 Jan 27.
Typ publikacji :
Journal Article
MeSH Terms :
Insurance, Health/*statistics & numerical data
Neoplasms/*therapy
Adolescent ; Adult ; Child ; Child, Preschool ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Male ; Quality of Life ; Survival Rate
Czasopismo naukowe
Tytuł :
Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort study.
Autorzy :
Demoor-Goldschmidt C; Cancer and Radiation Team, U1018 Inserm, Université Paris Saclay, Gustave Roussy, Villejuif, France. Electronic address: .
Supiot S; Radiotherapy Department, ICO - Gauducheau, Nantes, France.
Oberlin O; Pediatric Oncology, Institut Gustave Roussy, Villejuif, France.
Helfre S; Radiotherapy Department, Institut Curie, Paris, France.
Vigneron C; Radiotherapy Department, Centre Paul Strauss, Strasbourg, France.
Brillaud-Meflah V; Gynecology Department, Institut Bergonié, Bordeaux, France.
Bernier V; Radiotherapy Department, Centre Alexis Vautrin, Nancy, France.
Laprie A; Radiotherapy Department, Institut Claudius Regaud, Toulouse, France.
Ducassou A; Radiotherapy Department, Institut Claudius Regaud, Toulouse, France.
Claude L; Radiotherapy Department, Centre Léon Bérard, Lyon, France.
Mahé MA; Radiotherapy Department, ICO - Gauducheau, Nantes, France.
de Vathaire F; Cancer and Radiation Team, U1018 Inserm, Université Paris Saclay, Gustave Roussy, Villejuif, France.
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 Aug; Vol. 124 (2), pp. 200-203. Date of Electronic Publication: 2017 Jul 18.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Breast Neoplasms/*diagnosis
Breast Neoplasms/*etiology
Neoplasms/*radiotherapy
Neoplasms, Radiation-Induced/*diagnosis
Neoplasms, Second Primary/*diagnosis
Adult ; Breast/radiation effects ; Breast Neoplasms/pathology ; Early Detection of Cancer ; Female ; France ; Humans ; Mammary Glands, Human/radiation effects ; Mammography ; Middle Aged ; Neoplasms, Radiation-Induced/etiology ; Neoplasms, Radiation-Induced/pathology ; Neoplasms, Second Primary/etiology ; Neoplasms, Second Primary/pathology ; Radiotherapy/adverse effects ; Retrospective Studies ; Survivors ; Young Adult
Czasopismo naukowe
Tytuł :
Screening for psychological distress in very long-term adult survivors of childhood cancer.
Autorzy :
de Laage A; a Department of Pediatrics , Institut Gustave-Roussy , Villejuif , France.
Allodji R; b Radiation Epidemiology Group, Center for Research in Epidemiology and Population Health , Institut National de la Santé et de la Recherche Médicale, UMR 1018 , Villejuif , France.
Dauchy S; a Department of Pediatrics , Institut Gustave-Roussy , Villejuif , France.
Rivollet S; a Department of Pediatrics , Institut Gustave-Roussy , Villejuif , France.
Fayech C; a Department of Pediatrics , Institut Gustave-Roussy , Villejuif , France.
Fresneau B; a Department of Pediatrics , Institut Gustave-Roussy , Villejuif , France.
Oberlin O; a Department of Pediatrics , Institut Gustave-Roussy , Villejuif , France.
Pokaż więcej
Źródło :
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2016 Aug; Vol. 33 (5), pp. 295-313. Date of Electronic Publication: 2016 Sep 22.
Typ publikacji :
Journal Article
MeSH Terms :
Anxiety Disorders*/epidemiology
Anxiety Disorders*/etiology
Anxiety Disorders*/psychology
Neoplasms*/epidemiology
Neoplasms*/psychology
Stress, Psychological*/epidemiology
Stress, Psychological*/etiology
Stress, Psychological*/psychology
Surveys and Questionnaires*
Survivors/*psychology
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Educational and occupational outcomes of childhood cancer survivors 30 years after diagnosis: a French cohort study.
Autorzy :
Dumas A; CESP (Centre for Research in Epidemiology and Population Health) U1018, Inserm, 94807 Villejuif, France.; Social and Human Sciences Research Unit, Gustave Roussy, 94805 Villejuif, France.
Berger C; Department of Paediatric Haematology-Oncology, CHU Saint-Etienne, 42270 Saint-Priest-en-Jarez, France.; Rhône-Alpes Childhood Cancer Registry, 42000 Saint-Etienne, France.; Laboratory SNA-EPIS EA4607, Jean Monnet University), 42000 Saint-Etienne, France.
Auquier P; Quality of Life Research Unit (EA3279), APHM, Aix Marseille University, 13385 Marseille, France.
Michel G; Quality of Life Research Unit (EA3279), APHM, Aix Marseille University, 13385 Marseille, France.; Department of Paediatric Haematology-Oncology, La Timone, 13005 Marseille, France.
Fresneau B; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805 Villejuif, France.
Allodji RS; CESP (Centre for Research in Epidemiology and Population Health) U1018, Inserm, 94807 Villejuif, France.; Department of Clinical Research, Gustave Roussy, 94805 Villejuif, France.; Paris XI University.
Haddy N; CESP (Centre for Research in Epidemiology and Population Health) U1018, Inserm, 94807 Villejuif, France.; Department of Clinical Research, Gustave Roussy, 94805 Villejuif, France.; Paris XI University.
Rubino C; CESP (Centre for Research in Epidemiology and Population Health) U1018, Inserm, 94807 Villejuif, France.; Department of Clinical Research, Gustave Roussy, 94805 Villejuif, France.; Paris XI University.
Vassal G; Department of Clinical Research, Gustave Roussy, 94805 Villejuif, France.
Valteau-Couanet D; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805 Villejuif, France.
Thouvenin-Doulet S; Department of Paediatric Haematology-Oncology, CHU Saint-Etienne, 42270 Saint-Priest-en-Jarez, France.
Casagranda L; Rhône-Alpes Childhood Cancer Registry, 42000 Saint-Etienne, France.; Laboratory SNA-EPIS EA4607, Jean Monnet University), 42000 Saint-Etienne, France.
Pacquement H; Department of Paediatric Oncology, Institut Curie, 75005 Paris, France.
El-Fayech C; CESP (Centre for Research in Epidemiology and Population Health) U1018, Inserm, 94807 Villejuif, France.; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805 Villejuif, France.
Oberlin O; Department of Paediatric and Adolescent Oncology, Gustave Roussy, 94805 Villejuif, France.
Guibout C; CESP (Centre for Research in Epidemiology and Population Health) U1018, Inserm, 94807 Villejuif, France.; Department of Clinical Research, Gustave Roussy, 94805 Villejuif, France.; Paris XI University.
de Vathaire F; CESP (Centre for Research in Epidemiology and Population Health) U1018, Inserm, 94807 Villejuif, France.; Department of Clinical Research, Gustave Roussy, 94805 Villejuif, France.; Paris XI University.
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2016 Apr 26; Vol. 114 (9), pp. 1060-8.
Typ publikacji :
Journal Article
MeSH Terms :
Health Occupations/*trends
Neoplasms/*epidemiology
Adolescent ; Child ; Child, Preschool ; Cohort Studies ; Female ; France ; Humans ; Infant ; Infant, Newborn ; Male ; Outcome Assessment, Health Care ; Surveys and Questionnaires ; Survivors
Czasopismo naukowe
Tytuł :
Cardiac Diseases Following Childhood Cancer Treatment: Cohort Study.
Autorzy :
Haddy N; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.). .
Diallo S; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
El-Fayech C; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Schwartz B; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Pein F; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Hawkins M; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Veres C; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Oberlin O; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Guibout C; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Pacquement H; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Munzer M; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
N'Guyen TD; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Bondiau PY; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Berchery D; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Laprie A; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Scarabin PY; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Jouven X; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Bridier A; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Koscielny S; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Deutsch E; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Diallo I; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
de Vathaire F; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2016 Jan 05; Vol. 133 (1), pp. 31-8. Date of Electronic Publication: 2015 Oct 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*adverse effects
Heart Diseases/*etiology
Neoplasms/*drug therapy
Neoplasms/*radiotherapy
Adult ; Anthracyclines/adverse effects ; Antineoplastic Protocols ; Child ; Child, Preschool ; Cohort Studies ; Dose-Response Relationship, Drug ; Dose-Response Relationship, Radiation ; Female ; Heart Diseases/chemically induced ; Heart Diseases/epidemiology ; Humans ; Male ; Neoplasms/epidemiology ; Risk Factors
Czasopismo naukowe
Tytuł :
Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy.
Autorzy :
Allodji RS; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France. Electronic address: .
Schwartz B; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Veres C; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Haddy N; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Rubino C; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Le Deley MC; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Labbé M; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Diop F; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Jackson A; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Dayet F; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Benabdennebi A; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Llanas D; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Vu Bezin J; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Chavaudra J; Gustave Roussy, Villejuif, France.
Lefkopoulos D; Gustave Roussy, Villejuif, France.
Deutsch E; Gustave Roussy, Villejuif, France; Inserm, UMR 1030, Villejuif, France.
Oberlin O; Gustave Roussy, Villejuif, France.
de Vathaire F; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Diallo I; Inserm, Radiation Epidemiology Team, CESP-Unit 1018, Villejuif, France; Gustave Roussy, Villejuif, France; Paris Sud University, Orsay, France.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2015 Nov 01; Vol. 93 (3), pp. 658-67. Date of Electronic Publication: 2015 Aug 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Leukemia, Radiation-Induced*
Antineoplastic Agents/*adverse effects
Bone Marrow/*drug effects
Bone Marrow/*radiation effects
Leukemia/*chemically induced
Neoplasms/*therapy
Adolescent ; Analysis of Variance ; Antineoplastic Agents, Alkylating/adverse effects ; Case-Control Studies ; Child ; Child, Preschool ; Confidence Intervals ; Female ; Humans ; Infant ; Male ; Neoplasms, Second Primary/etiology ; Odds Ratio ; Platinum Compounds/adverse effects ; Podophyllotoxin/adverse effects ; Radiation Dosage
Czasopismo naukowe
Tytuł :
Educational trajectories after childhood cancer: When illness experience matters.
Autorzy :
Dumas A; Gustave Roussy, Department of Clinical Research, Social and Human Sciences Research Unit, Villejuif, F-94805, France. Electronic address: .
Cailbault I; Gustave Roussy, Department of Clinical Research, Social and Human Sciences Research Unit, Villejuif, F-94805, France. Electronic address: .
Perrey C; Gustave Roussy, Department of Clinical Research, Social and Human Sciences Research Unit, Villejuif, F-94805, France. Electronic address: .
Oberlin O; Gustave Roussy, Department of Pediatric and Adolescent Oncology, Villejuif, F-94805, France. Electronic address: Odile.OBERLIN@gustaveroussy.fr.
De Vathaire F; CESP Centre for Research in Epidemiology and Population Health, U1018, Radiation Epidemiology Team, Villejuif, F-94807, France; Gustave Roussy, Villejuif, F-94805, France; Université Paris XI, Villejuif, 94800, France. Electronic address: .
Amiel P; Gustave Roussy, Department of Clinical Research, Social and Human Sciences Research Unit, Villejuif, F-94805, France. Electronic address: .
Pokaż więcej
Źródło :
Social science & medicine (1982) [Soc Sci Med] 2015 Jun; Vol. 135, pp. 67-74. Date of Electronic Publication: 2015 Apr 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Educational Status*
Life Change Events*
Neoplasms*
Survivors*
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Cohort Studies ; Female ; France ; Humans ; Male ; Middle Aged ; Occupations ; Qualitative Research ; Social Adjustment
Czasopismo naukowe
Tytuł :
Patients in pediatric phase I and early phase II clinical oncology trials at Gustave Roussy: a 13-year center experience.
Autorzy :
Bautista F; Departments of *Pediatric and Adolescent Oncology †Biostatistics and Epidemiology ‡Radiology §CNRS UMR 8203 Vectorology and Anticancer Therapeutics, Université Paris-Sud 11, Gustave Roussy, Villejuif, France.
Di Giannatale A
Dias-Gastellier N
Fahd M
Valteau-Couanet D
Couanet D
Grill J
Brugières L
Dufour C
Gaspar N
Minard-Colin V
Kalifa C
Oberlin O
Patte C
Vassal G
Geoerger B
Pokaż więcej
Źródło :
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2015 Mar; Vol. 37 (2), pp. e102-10.
Typ publikacji :
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
MeSH Terms :
Hospitalization/*statistics & numerical data
Neoplasm Recurrence, Local/*mortality
Neoplasm Recurrence, Local/*therapy
Neoplasms/*mortality
Neoplasms/*therapy
Adolescent ; Adult ; Child ; Child, Preschool ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Infant ; Infant, Newborn ; Male ; Meta-Analysis as Topic ; Prognosis ; Survival Rate ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
[Fertility preservation in children and teenagers with cancer].
Autorzy :
Sudour-Bonnange H; Centre Oscar-Lambret, Département de Pédiatrie, 3 Rue Fréderic-Combemale, 59020 Lille cedex, France. h-sudour@o-lambret.fr
Tabone MD
Thomas-Teinturier C
Pacquement H
Oberlin O
Marec-Berard P
Laurence V
Aubier F
Duranteau L
Bernier-Chastagner V
Michel G
Rives N
Berger C
Pokaż więcej
Transliterated Title :
Préservation de la fertilité chez les enfants et adolescents traités pour un cancer.
Źródło :
Bulletin du cancer [Bull Cancer] 2013 Jul-Aug; Vol. 100 (7-8), pp. 727-35.
Typ publikacji :
English Abstract; Journal Article; Review
MeSH Terms :
Fertility Preservation/*methods
Neoplasms/*therapy
Adolescent ; Child ; Cryopreservation/methods ; Female ; Humans ; Infertility, Female/prevention & control ; Infertility, Male/prevention & control ; Male ; Quality of Life ; Sex Factors ; Survivors
Czasopismo naukowe
Tytuł :
Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature.
Autorzy :
Thomas-Teinturier C; Radiation Epidemiology Group, Center for Research in Epidemiology and Population Health (CESP) - INSERM U1018, Villejuif F-94800, France.
El Fayech C
Oberlin O
Pacquement H
Haddy N
Labbé M
Veres C
Guibout C
Diallo I
De Vathaire F
Pokaż więcej
Źródło :
Human reproduction (Oxford, England) [Hum Reprod] 2013 Feb; Vol. 28 (2), pp. 488-95. Date of Electronic Publication: 2012 Nov 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Menopause*
Menopause, Premature*
Survivors*
Antineoplastic Agents, Alkylating/*adverse effects
Neoplasms/*complications
Radiotherapy/*adverse effects
Adult ; Age Factors ; Antineoplastic Agents, Alkylating/administration & dosage ; Cohort Studies ; Female ; Humans ; Middle Aged ; Multivariate Analysis ; Neoplasms/drug therapy ; Neoplasms/radiotherapy ; Ovary/radiation effects ; Ovary/surgery ; Radiotherapy Dosage ; Regression Analysis ; Risk Factors
Czasopismo naukowe
Tytuł :
Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study.
Autorzy :
de Vathaire F; Radiation Epidemiology Group, INSERM U1018, Villejuif, France; Institut Gustave Roussy, Villejuif, France; Université Paris-Sud, Villejuif, France. />El-Fayech C
Ben Ayed FF
Haddy N
Guibout C
Winter D
Thomas-Teinturier C
Veres C
Jackson A
Pacquement H
Schlumberger M
Hawkins M
Diallo I
Oberlin O
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2012 Oct; Vol. 13 (10), pp. 1002-10. Date of Electronic Publication: 2012 Aug 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus/*etiology
Neoplasms/*radiotherapy
Pancreas/*radiation effects
Adolescent ; Body Mass Index ; Child ; Child, Preschool ; Cohort Studies ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Radiation Dosage ; Retrospective Studies ; Risk ; Survivors
Czasopismo naukowe
Tytuł :
[Offspring of childhood cancer survivors].
Autorzy :
Dufour C; Département de Pédiatrie, Institut Gustave-Roussy, Villejuif, France. />Oberlin O
De Vathaire F
Pokaż więcej
Transliterated Title :
Descendance des patients guéris d'un cancer.
Źródło :
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie [Arch Pediatr] 2010 Jun; Vol. 17 (6), pp. 926-7.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Survivors*
Abnormalities, Drug-Induced/*etiology
Abnormalities, Radiation-Induced/*etiology
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Neoplasms/*drug therapy
Neoplasms/*radiotherapy
Neoplasms, Radiation-Induced/*etiology
Pregnancy Complications/*etiology
Radiotherapy/*adverse effects
Adult ; Child ; Female ; Fetal Growth Retardation/etiology ; Follow-Up Studies ; Humans ; Infant, Newborn ; Male ; Mutagenicity Tests ; Neoplasms/chemically induced ; Pregnancy ; Sex Ratio
Czasopismo naukowe
Tytuł :
Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer.
Autorzy :
Tukenova M; L'Institut National de la Santé et de la Recherche Médicale,Institut Gustave Roussy, 94805 Villejuif Cedex, France.
Guibout C
Oberlin O
Doyon F
Mousannif A
Haddy N
Guérin S
Pacquement H
Aouba A
Hawkins M
Winter D
Bourhis J
Lefkopoulos D
Diallo I
de Vathaire F
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Mar 10; Vol. 28 (8), pp. 1308-15. Date of Electronic Publication: 2010 Feb 08.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*adverse effects
Cardiovascular Diseases/*mortality
Neoplasms/*drug therapy
Neoplasms/*radiotherapy
Adolescent ; Adult ; Anthracyclines/administration & dosage ; Anthracyclines/adverse effects ; Cardiovascular Diseases/etiology ; Cause of Death ; Child ; Child, Preschool ; Dose-Response Relationship, Drug ; Dose-Response Relationship, Radiation ; Female ; Follow-Up Studies ; France/epidemiology ; Humans ; Male ; Middle Aged ; Mortality ; Multivariate Analysis ; Radiotherapy/adverse effects ; Survivors ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
[Osteoporosis and cancer in children and adolescents].
Autorzy :
Oberlin O; Département d'Oncologie Pédiatrique, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. odile.oberlin@igr.fr
Brugières L
Pokaż więcej
Transliterated Title :
Ostéoporose et cancers de l'enfant et de l'adolescent.
Źródło :
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie [Arch Pediatr] 2009 Jun; Vol. 16 (6), pp. 622-4.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasms/*therapy
Osteoporosis/*etiology
Adolescent ; Child ; Child, Preschool ; Humans ; Infant ; Infant, Newborn
Czasopismo naukowe
Tytuł :
Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
Autorzy :
Ridola V; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France.
Fawaz O
Aubier F
Bergeron C
de Vathaire F
Pichon F
Orbach D
Gentet JC
Schmitt C
Dufour C
Oberlin O
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2009 Mar; Vol. 45 (5), pp. 814-8. Date of Electronic Publication: 2009 Feb 11.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents, Alkylating/*adverse effects
Cyclophosphamide/*adverse effects
Ifosfamide/*adverse effects
Neoplasms/*drug therapy
Testis/*drug effects
Adolescent ; Adult ; Antineoplastic Agents, Alkylating/administration & dosage ; Antineoplastic Agents, Alkylating/therapeutic use ; Biomarkers/blood ; Child ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Follicle Stimulating Hormone/blood ; Follow-Up Studies ; Humans ; Ifosfamide/administration & dosage ; Ifosfamide/therapeutic use ; Luteinizing Hormone/blood ; Lymphoma, Non-Hodgkin/drug therapy ; Male ; Sarcoma/drug therapy ; Survivors ; Testicular Diseases/blood ; Testicular Diseases/chemically induced ; Testis/physiology ; Testosterone/blood
Czasopismo naukowe
Tytuł :
Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
Autorzy :
Nguyen F; INSERM U 605, Villejuif, France; Institut Gustave Roussy, Villejuif cedex, France. />Rubino C
Guerin S
Diallo I
Samand A
Hawkins M
Oberlin O
Lefkopoulos D
De Vathaire F
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2008 Mar 01; Vol. 70 (3), pp. 908-15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Radiotherapy Dosage*
Survivors*
Neoplasms/*radiotherapy
Neoplasms, Radiation-Induced/*epidemiology
Neoplasms, Second Primary/*epidemiology
Adolescent ; Antineoplastic Agents/adverse effects ; Bone Neoplasms/drug therapy ; Bone Neoplasms/radiotherapy ; Child ; Child, Preschool ; Cohort Studies ; Dose-Response Relationship, Radiation ; England/epidemiology ; Female ; France/epidemiology ; Hodgkin Disease/drug therapy ; Hodgkin Disease/radiotherapy ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Neoplasms/drug therapy ; Regression Analysis ; Risk ; Sarcoma, Ewing/drug therapy ; Sarcoma, Ewing/radiotherapy
Czasopismo naukowe
Tytuł :
Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
Autorzy :
Guérin S; L'Institut National de la Santé et de la Recherche Médicale, Villejuif, France.
Hawkins M
Shamsaldin A
Guibout C
Diallo I
Oberlin O
Brugières L
de Vathaire F
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2007 Jul 01; Vol. 25 (19), pp. 2833-9.
Typ publikacji :
Journal Article
MeSH Terms :
Hodgkin Disease/*therapy
Neoplasms/*drug therapy
Neoplasms/*radiotherapy
Neoplasms, Germ Cell and Embryonal/*therapy
Neoplasms, Second Primary/*etiology
Retinoblastoma/*therapy
Sarcoma/*therapy
Adolescent ; Adult ; Case-Control Studies ; Child ; Child, Preschool ; Disease Susceptibility ; Female ; Hodgkin Disease/pathology ; Humans ; Infant ; Male ; Middle Aged ; Neoplasms, Germ Cell and Embryonal/pathology ; Retinoblastoma/pathology ; Sarcoma/pathology
Czasopismo naukowe
Tytuł :
[The outcome, in adulthood, of children treated for cancer].
Autorzy :
Oberlin O; Departement de pediatrie, institut Gustav-Roussy, 94805 Villejuif Cedex. oberlin@igr.fr
Pokaż więcej
Transliterated Title :
Le devenir, a l'age adulte, de enfants traites pour un cancer.
Źródło :
La Revue du praticien [Rev Prat] 2007 May 31; Vol. 57 (10), pp. 1095.
Typ publikacji :
Journal Article
MeSH Terms :
Survivors*
Neoplasms/*therapy
Adolescent ; Adult ; Child ; Child, Preschool ; Chronic Disease ; Cohort Studies ; Follow-Up Studies ; Health Status ; Humans ; Life Expectancy ; Longitudinal Studies ; Risk Factors ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies